A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation

OBJECTIVES: This study assessed the efficacy and safety of plecanatide, a guanylate cyclase-C (GC-C) agonist and the first uroguanylin analog approved for the treatment of chronic idiopathic constipation (CIC). METHODS: This phase III, multicenter, double-blind, placebo-controlled study randomized 1...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Gastroenterol
Main Authors: Miner Jr, Philip B, Koltun, William D, Wiener, Gregory J, De La Portilla, Marianela, Prieto, Blas, Shailubhai, Kunwar, Layton, Mary Beth, Barrow, Laura, Magnus, Leslie, Griffin, Patrick H
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2017
Assuntos:
Functional GI Disorders
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5415706/
https://ncbi.nlm.nih.gov/pubmed/28169285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ajg.2016.611
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados